NASDAQ: INDVIndivior PLC Stock
$17.58+0.33 (+1.91%)
Updated Apr 26, 2024
INDV Price
$17.58
Fair Value Price
N/A
Market Cap
$2.40B
52 Week Low
$14.38
52 Week High
$26.50
P/E
439.5x
P/B
240.01x
P/S
2.6x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.12B
Earnings
$5.00M
Gross Margin
82.8%
Operating Margin
3.91%
Profit Margin
0.4%
Debt to Equity
144.3
Operating Cash Flow
-$301M
Beta
1.43
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how INDV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
INDV is poor value based on its earnings relative to its share price (439.5x), compared to the US market average (41.14x)
P/E vs Market Valuation
INDV is poor value based on its earnings relative to its share price (439.5x), compared to the US Drug Manufacturers - Specialty & Generic industry average (33.92x)
P/E vs Industry Valuation
INDV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more INDV due diligence checks available for Premium users.
Be the first to know about important INDV news, forecast changes, insider trades & much more!
INDV News
Valuation
INDV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
439.5x
Industry
33.92x
Market
41.14x
INDV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
INDV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
INDV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
240.01x
Industry
2.09x
INDV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
INDV's financial health
Profit margin
Revenue
$284.0M
Net Income
$47.0M
Profit Margin
16.5%
INDV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
INDV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.5B
Liabilities
$1.4B
Debt to equity
144.3
INDV's short-term liabilities ($861.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INDV's short-term assets ($796.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INDV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$25.0M
Investing
$25.0M
Financing
-$38.0M
INDV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
INDV vs Pharmaceutical Stocks
Indivior Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.